FSTX
Closed
Fstar Therapeutics Inc
7.12
0.00 (0.00%)
Last Update: 17 Mar 2023 16:30:00
Yesterday: 7.12
Day's Range: 7.12 - 7.12
Send
sign up or login to leave a comment!
When Written:
7.12
FStar Therapeutics Inc is a biotechnology company that develops novel therapies for cancer and inflammatory diseases. The company's proprietary platform technology, called Modular Antibody Technology, allows for the rapid development of highly specific and potent antibodies against disease targets.
FStar Therapeutics has several pipeline programs, including FS120, a first-in-class antibody targeting the immune checkpoint receptor CD39, which is being developed for the treatment of cancer. The company is also developing FS222, an antibody targeting IL-2Rbeta, for the treatment of autoimmune and inflammatory diseases.
FStar Therapeutics was founded in 2006 and is headquartered in Cambridge, Massachusetts. The company has partnerships with leading pharmaceutical companies, including Merck and AbbVie.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
FStar Therapeutics has several pipeline programs, including FS120, a first-in-class antibody targeting the immune checkpoint receptor CD39, which is being developed for the treatment of cancer. The company is also developing FS222, an antibody targeting IL-2Rbeta, for the treatment of autoimmune and inflammatory diseases.
FStar Therapeutics was founded in 2006 and is headquartered in Cambridge, Massachusetts. The company has partnerships with leading pharmaceutical companies, including Merck and AbbVie.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








